malaria no more united kingdom
malaria no more united kingdom Company Information
Group Structure
View All
Industry
Other social work activities without accommodation n.e.c.
Registered Address
85 great portland street, first floor, london, W1W 7LT
Website
www.malarianomore.org.ukmalaria no more united kingdom Estimated Valuation
Pomanda estimates the enterprise value of MALARIA NO MORE UNITED KINGDOM at £3.1m based on a Turnover of £4.7m and 0.65x industry multiple (adjusted for size and gross margin).
malaria no more united kingdom Estimated Valuation
Pomanda estimates the enterprise value of MALARIA NO MORE UNITED KINGDOM at £0 based on an EBITDA of £-234k and a 6.81x industry multiple (adjusted for size and gross margin).
malaria no more united kingdom Estimated Valuation
Pomanda estimates the enterprise value of MALARIA NO MORE UNITED KINGDOM at £4.7m based on Net Assets of £2m and 2.4x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Malaria No More United Kingdom Overview
Malaria No More United Kingdom is a live company located in london, W1W 7LT with a Companies House number of 06648679. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in July 2008, it's largest shareholder is unknown. Malaria No More United Kingdom is a established, small sized company, Pomanda has estimated its turnover at £4.7m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Malaria No More United Kingdom Health Check
Pomanda's financial health check has awarded Malaria No More United Kingdom a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
5 Weak
Size
annual sales of £4.7m, make it larger than the average company (£456.2k)
£4.7m - Malaria No More United Kingdom
£456.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6.2%)
4% - Malaria No More United Kingdom
6.2% - Industry AVG
Production
with a gross margin of 85.5%, this company has a comparable cost of product (85.5%)
85.5% - Malaria No More United Kingdom
85.5% - Industry AVG
Profitability
an operating margin of -5.2% make it less profitable than the average company (3%)
-5.2% - Malaria No More United Kingdom
3% - Industry AVG
Employees
with 30 employees, this is above the industry average (12)
30 - Malaria No More United Kingdom
12 - Industry AVG
Pay Structure
on an average salary of £71.8k, the company has a higher pay structure (£25.7k)
£71.8k - Malaria No More United Kingdom
£25.7k - Industry AVG
Efficiency
resulting in sales per employee of £157.2k, this is more efficient (£42.8k)
£157.2k - Malaria No More United Kingdom
£42.8k - Industry AVG
Debtor Days
it gets paid by customers after 9 days, this is earlier than average (12 days)
9 days - Malaria No More United Kingdom
12 days - Industry AVG
Creditor Days
its suppliers are paid after 128 days, this is slower than average (7 days)
128 days - Malaria No More United Kingdom
7 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Malaria No More United Kingdom
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 55 weeks, this is less cash available to meet short term requirements (226 weeks)
55 weeks - Malaria No More United Kingdom
226 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 52.1%, this is a higher level of debt than the average (13.5%)
52.1% - Malaria No More United Kingdom
13.5% - Industry AVG
MALARIA NO MORE UNITED KINGDOM financials
Malaria No More United Kingdom's latest turnover from December 2023 is £4.7 million and the company has net assets of £2 million. According to their latest financial statements, Malaria No More United Kingdom has 30 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4,716,491 | 4,077,708 | 3,734,140 | 4,216,567 | 2,534,098 | 2,930,641 | 2,246,806 | 2,026,811 | 1,063,296 | 1,081,439 | 983,223 | 1,074,843 | 1,140,695 | 1,119,724 | |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -63,670 | -351,379 | 483,330 | 804,586 | 83,479 | 6,053 | -315,657 | 96,479 | -159,110 | 208,503 | 203,557 | -303,005 | 200,365 | 678,331 | |
| Tax | |||||||||||||||
| Profit After Tax | -63,670 | -351,379 | 483,330 | 804,586 | 83,479 | 6,053 | -315,657 | 96,479 | -159,110 | 208,503 | 203,557 | -303,005 | 200,365 | 678,331 | |
| Dividends Paid | |||||||||||||||
| Retained Profit | -63,670 | -351,379 | 483,330 | 804,586 | 83,479 | 6,053 | -315,657 | 96,479 | -159,110 | 208,503 | 203,557 | -303,005 | 200,365 | 678,331 | |
| Employee Costs | 2,152,552 | 1,826,834 | 1,869,289 | 1,628,170 | 1,067,344 | 1,052,512 | 861,995 | 727,875 | 695,074 | 466,008 | 421,360 | 413,206 | 350,575 | 238,471 | |
| Number Of Employees | 30 | 25 | 30 | 25 | 16 | 16 | 16 | 12 | 12 | 9 | 8 | 7 | 6 | 3 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 15,447 | 12,805 | 9,249 | 6,355 | 3,831 | 3,095 | 3,943 | 3,830 | 8,537 | 1,753 | |||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 1,544,457 | 502,571 | |||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 1,559,904 | 515,376 | 9,249 | 6,355 | 3,831 | 3,095 | 3,943 | 3,830 | 8,537 | 1,753 | |||||
| Stock & work in progress | 143 | 425 | |||||||||||||
| Trade Debtors | 125,353 | 120,999 | 448,526 | 313,857 | 1,049 | 15,645 | 426,146 | 30,371 | 31,000 | 42,660 | 264,894 | 149,554 | 128,635 | 247,368 | 303,922 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 127,872 | 152,114 | 17,792 | 10,749 | 32,407 | 17,171 | 18,191 | 7,097 | 6,184 | 3,704 | 6,435 | 508 | |||
| Cash | 2,287,406 | 4,722,665 | 3,614,160 | 3,524,316 | 3,418,779 | 1,266,321 | 2,131,422 | 2,503,732 | 1,647,677 | 1,560,125 | 563,689 | 418,685 | 833,157 | 402,420 | 168,947 |
| misc current assets | |||||||||||||||
| total current assets | 2,540,631 | 4,995,778 | 4,080,478 | 3,848,922 | 3,452,235 | 1,299,137 | 2,575,759 | 2,541,200 | 1,684,861 | 1,602,785 | 828,583 | 568,382 | 965,921 | 656,223 | 473,377 |
| total assets | 4,100,535 | 5,511,154 | 4,089,727 | 3,855,277 | 3,456,066 | 1,302,232 | 2,579,702 | 2,545,030 | 1,693,398 | 1,604,538 | 828,583 | 568,382 | 965,921 | 656,223 | 473,377 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 241,452 | 57,925 | 67,615 | 72,884 | 100,077 | 30,172 | 143,740 | 84,645 | 55,807 | 248,000 | 17,259 | 2,592 | 16,553 | 7,181 | 4,555 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,896,652 | 3,446,340 | 1,666,414 | 1,910,025 | 2,288,207 | 287,757 | 1,457,712 | 1,166,478 | 440,163 | 60,511 | 23,480 | 610,615 | 7,284 | 27,429 | |
| total current liabilities | 2,138,104 | 3,504,265 | 1,734,029 | 1,982,909 | 2,388,284 | 317,929 | 1,601,452 | 1,251,123 | 495,970 | 248,000 | 77,770 | 26,072 | 627,168 | 14,465 | 31,984 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 2,138,104 | 3,504,265 | 1,734,029 | 1,982,909 | 2,388,284 | 317,929 | 1,601,452 | 1,251,123 | 495,970 | 248,000 | 77,770 | 26,072 | 627,168 | 14,465 | 31,984 |
| net assets | 1,962,431 | 2,006,889 | 2,355,698 | 1,872,368 | 1,067,782 | 984,303 | 978,250 | 1,293,907 | 1,197,428 | 1,356,538 | 750,813 | 542,310 | 338,753 | 641,758 | 441,393 |
| total shareholders funds | 1,962,431 | 2,006,889 | 2,355,698 | 1,872,368 | 1,067,782 | 984,303 | 978,250 | 1,293,907 | 1,197,428 | 1,356,538 | 750,813 | 542,310 | 338,753 | 641,758 | 441,393 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 13,713 | 10,675 | 7,660 | 4,417 | 4,449 | 1,972 | 5,802 | 4,707 | 4,708 | 877 | |||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | -143 | -282 | 425 | ||||||||||||
| Debtors | -19,888 | -193,205 | 141,712 | 291,150 | 640 | -411,521 | 406,869 | 284 | -5,476 | -222,234 | 115,340 | 17,215 | -121,464 | -50,627 | 304,430 |
| Creditors | 183,527 | -9,690 | -5,269 | -27,193 | 69,905 | -113,568 | 59,095 | 28,838 | -192,193 | 230,741 | 14,667 | -13,961 | 9,372 | 2,626 | 4,555 |
| Accruals and Deferred Income | -1,549,688 | 1,779,926 | -243,611 | -378,182 | 2,000,450 | -1,169,955 | 291,234 | 726,315 | 440,163 | -60,511 | 37,031 | -587,135 | 603,331 | -20,145 | 27,429 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -1,124 | -5,915 | -11,492 | ||||||||||||
| Change in Investments | 1,041,886 | 502,571 | |||||||||||||
| cash flow from investments | -1,041,886 | -502,571 | -1,124 | -5,915 | -11,492 | ||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 19,212 | 2,570 | -236,938 | ||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -2,435,259 | 1,108,505 | 89,844 | 105,537 | 2,152,458 | -865,101 | -372,310 | 856,055 | 87,552 | 996,436 | 145,004 | -414,472 | 430,737 | 233,473 | 168,947 |
| overdraft | |||||||||||||||
| change in cash | -2,435,259 | 1,108,505 | 89,844 | 105,537 | 2,152,458 | -865,101 | -372,310 | 856,055 | 87,552 | 996,436 | 145,004 | -414,472 | 430,737 | 233,473 | 168,947 |
malaria no more united kingdom Credit Report and Business Information
Malaria No More United Kingdom Competitor Analysis
Perform a competitor analysis for malaria no more united kingdom by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in W1W area or any other competitors across 12 key performance metrics.
malaria no more united kingdom Ownership
MALARIA NO MORE UNITED KINGDOM group structure
Malaria No More United Kingdom has 1 subsidiary company.
Ultimate parent company
MALARIA NO MORE UNITED KINGDOM
06648679
1 subsidiary
malaria no more united kingdom directors
Malaria No More United Kingdom currently has 9 directors. The longest serving directors include Mr David Reddy (May 2019) and Mr Norman Mbazima (Apr 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Reddy | Switzerland | 63 years | May 2019 | - | Director |
| Mr Norman Mbazima | England | 66 years | Apr 2020 | - | Director |
| Mr Norman Mbazima | England | 66 years | Apr 2020 | - | Director |
| Ms Eva Norman | England | 57 years | Apr 2020 | - | Director |
| Mr Feyisola Olubodun | Nigeria | 45 years | Feb 2022 | - | Director |
| Mr Geoffrey Love | England | 55 years | Sep 2023 | - | Director |
| Mr Stewart Cox | England | 57 years | Sep 2023 | - | Director |
| Dr Branwen Hennig | England | 52 years | Feb 2024 | - | Director |
| Ms Scheaffer Okore | England | 39 years | Feb 2024 | - | Director |
P&L
December 2023turnover
4.7m
+16%
operating profit
-247.7k
0%
gross margin
85.5%
-3.83%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2m
-0.02%
total assets
4.1m
-0.26%
cash
2.3m
-0.52%
net assets
Total assets minus all liabilities
malaria no more united kingdom company details
company number
06648679
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
July 2008
age
17
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
SAYER VINCENT LLP
address
85 great portland street, first floor, london, W1W 7LT
Bank
CAF BANK (UK) LIMITED
Legal Advisor
-
malaria no more united kingdom Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to malaria no more united kingdom. Currently there are 2 open charges and 0 have been satisfied in the past.
malaria no more united kingdom Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MALARIA NO MORE UNITED KINGDOM. This can take several minutes, an email will notify you when this has completed.
malaria no more united kingdom Companies House Filings - See Documents
| date | description | view/download |
|---|
